INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
3,430,869
Share change
+2,028,323
Total reported value
$83,201,000
Price per share
$24.24
Number of holders
19
Value change
+$50,093,159
Number of buys
14
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q2 2020

As of 30 Jun 2020, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,430,869 shares. The largest 10 holders included NEW YORK LIFE INVESTMENT MANAGEMENT LLC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, MORGAN STANLEY, Centric Wealth Management, BANK OF AMERICA CORP /DE/, FLOW TRADERS U.S. LLC, Elevated Capital Advisors, LLC, RAYMOND JAMES & ASSOCIATES, and Teamwork Financial Advisors, LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.